The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Up­dat­ed: In­di­an man­u­fac­tur­er un­der scruti­ny af­ter cough syrups linked to deaths in West Africa

3 years ago
Pharma

CSL Se­qirus snaps up $30M+ BAR­DA con­tract to de­vel­op in­fluen­za vac­cine at its ex­pand­ed fa­cil­i­ty in NC

3 years ago
Pharma

BioN­Tech al­lies with Aus­tralian state, ini­tial­iz­ing plans to con­struct new R&D and man­u­fac­tur­ing fa­cil­i­ties

3 years ago
Deals

Roche breaks ground on ex­pan­sion at New Jer­sey man­u­fac­tur­ing site

3 years ago

Man­u­fac­tur­ing roundup: Cam­brex, Mil­li­pore­Sig­ma open new Eu­ro­pean fa­cil­i­ties in on­go­ing ex­pan­sion ef­forts

3 years ago

Dutch CD­MO In­travacc gets NIH grant of up to $14.6M to make gon­or­rhea vac­cine

3 years ago

Mer­ck­'s $500M bet on Sin­ga­pore leads to new man­u­fac­tur­ing sites mak­ing Keytru­da, Gar­dasil and fu­ture in­halers

3 years ago
Pharma

CNS-fo­cused gene ther­a­py biotech forges man­u­fac­tur­ing deal for hear­ing loss drug

3 years ago
Deals
Cell/Gene Tx

Two CRLs lat­er, Illi­nois-based CD­MO hit with FDA warn­ing let­ter over 's­pore-form­ing' bac­te­ria and fun­gi

3 years ago
FDA+

Lentivi­ral vec­tor ramp-up: J&J and Leg­end to in­vest $500M in New Jer­sey man­u­fac­tur­ing to sup­port Carvyk­ti

3 years ago
Pharma

Kite Phar­ma gets FDA to sign off on new Cal­i­for­nia-based vec­tor man­u­fac­tur­ing fa­cil­i­ty

3 years ago
Cell/Gene Tx

Take­da to pull key hy­poparathy­roidism drug from the mar­ket af­ter years of man­u­fac­tur­ing woes

3 years ago

Am­pli­fy­Bio scoops up lab space and oth­er as­sets from PACT Phar­ma as cell ther­a­py biotech read­justs

3 years ago
Deals
Cell/Gene Tx

FDA's ad­vanced ther­a­pies of­fice pro­vides more clar­i­ty on gene ther­a­py CMC con­sid­er­a­tions

3 years ago
Pharma
Cell/Gene Tx

Vor Bio opts to keep man­u­fac­tur­ing op­er­a­tions in-house for de­vel­op­ing stem cell, CAR-T ther­a­pies

3 years ago
Pharma

Man­u­fac­tur­ing roundup: Ace­to re­brands to Actylis; WuXi STA opens an­oth­er fa­cil­i­ty

3 years ago

As win­ter ap­proach­es, a Eu­ro­pean gener­ics group rais­es alarm over en­er­gy prices for man­u­fac­tur­ers

3 years ago
Pharma

Man­u­fac­tur­ing sites in Ger­many and Chi­na hit with warn­ing let­ters over QC and clean­ing is­sues

3 years ago
Pharma
FDA+

Emer­gent clos­es on buy­ing small­pox drug Tem­bexa from Chimerix with a $238M pay­ment

3 years ago
Deals
Pharma

Ipsen be­comes the lat­est phar­ma to ex­pand in Ire­land, with a $50M in­vest­ment in its fa­cil­i­ty in Dublin sub­urbs

3 years ago
Pharma

Fu­ji­film con­tin­ues CD­MO ex­pan­sion, break­ing ground on $435M UK site

3 years ago

An­oth­er Cipla site lands a Form 483 over clean­ing is­sues and QC con­trols

3 years ago
Pharma
FDA+

EMA warns of short­ages of two Boehringer heart drugs due to a spike in de­mand

3 years ago
Pharma

Man­u­fac­tur­ing roundup: Lon­za fin­ish­es ex­pand­ing Visp site; CBM to pro­duce jCyte’s cell ther­a­py

3 years ago
First page Previous page 43444546474849 Next page Last page
A service from the Financial Times